{"schema_version":"secwatch.filing_event.v1","accession":"0001588978-25-000004","form_type":"8-K","ticker":"PRCT","cik":"0001588978","company_name":"PROCEPT BioRobotics Corp","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.092445+00:00","generated_at":"2026-05-26T04:46:07.406369+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)","bullets":["Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).","FY2024 rev $224.5M (+65%); net loss narrowed to $91.4M from $105.9M; adj EBITDA loss $61.1M vs $86.5M.","FY2025 guidance: rev ~$320M (+42%); gross margin ~64.5%; adj EBITDA loss ~$35M.","Cash $333.7M, debt $52.0M; US install base 505 AquaBeam/HYDROS systems.","Q4 saline shortage delayed ~10-20% of Aquablation procedures, impacting handpiece order patterns."],"urls":{"canonical":"https://secwatch.observer/filing/0001588978-25-000004","json":"https://secwatch.observer/filing/0001588978-25-000004.json","markdown":"https://secwatch.observer/filing/0001588978-25-000004.md","text":"https://secwatch.observer/filing/0001588978-25-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1588978/000158897825000004/0001588978-25-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1588978/000158897825000004/prct-20250225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T04:46:07.406369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}